Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07332923
What this trial is testing

Predicting HIF-2α Levels in Clear Cell Kidney Cancer Using Machine Learning

Who this might be right for
Renal Clear Cell CarcinomaHIF-2αRadiomics+1 more
First Affiliated Hospital of Fujian Medical University 500
Testing effectiveness (Phase 2)UnknownNCT02787915
What this trial is testing

DC1s-CTL Cellular Therapy for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Xuzhou Medical University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05128487
What this trial is testing

NDI 1150-101 in Patients With Solid Tumors

Who this might be right for
Solid TumorRenal Cell Carcinoma (Kidney Cancer)Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+1 more
Nimbus Saturn, Inc. 106
Testing effectiveness (Phase 2)Ended earlyNCT00485563
What this trial is testing

A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Endocyte 12
Not applicableStudy completedNCT01404104
What this trial is testing

Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
St. Joseph's Healthcare Hamilton 11
Testing effectiveness (Phase 2)Study completedNCT01566747
What this trial is testing

Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5

Who this might be right for
Renal Cell Carcinoma
Cancer Trials Ireland 43
Large-scale testing (Phase 3)Ended earlyNCT03408652
What this trial is testing

Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted Therapies

Who this might be right for
Metastatic Renal Cell Carcinoma
Centre Leon Berard 1
Early research (Phase 1)Not Yet RecruitingNCT07500805
What this trial is testing

UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma

Who this might be right for
CD70-positive Advanced Renal Clear Cell Carcinoma
UTC Therapeutics Inc. 21
Testing effectiveness (Phase 2)UnknownNCT05124431
What this trial is testing

Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Fudan University 30
Not applicableUnknownNCT05005195
What this trial is testing

Yorkshire Kidney Screening Trial

Who this might be right for
Renal Cell Carcinoma
University of Leeds 5,850
Very early researchStudy completedNCT03071328
What this trial is testing

INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Urothelial CarcinomaMetastatic Renal Cell Carcinoma
Duke University 10
Testing effectiveness (Phase 2)Ended earlyNCT02959554
What this trial is testing

Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease Control

Who this might be right for
Metastatic Renal Cell Carcinoma
AIO-Studien-gGmbH 49
Testing effectiveness (Phase 2)Looking for participantsNCT07516366
What this trial is testing

Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

Who this might be right for
Clear Cell Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8Stage III Renal Cell Cancer AJCC v8+1 more
National Cancer Institute (NCI) 16
Large-scale testing (Phase 3)Active Not RecruitingNCT03937219
What this trial is testing

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Exelixis 855
Early research (Phase 1)Looking for participantsNCT06399419
What this trial is testing

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+5 more
Osel, Inc. 28
Testing effectiveness (Phase 2)Looking for participantsNCT07167329
What this trial is testing

Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial

Who this might be right for
Von Hippel LindauVon Hippel Lindau DiseaseVon Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma+5 more
José Claudio Casali da Rocha 100
Testing effectiveness (Phase 2)Ended earlyNCT04267120
What this trial is testing

Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)

Who this might be right for
Renal Cell Carcinoma
Washington University School of Medicine 11
Early research (Phase 1)Ended earlyNCT04458259
What this trial is testing

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Who this might be right for
Neoplasm Metastasis
Pfizer 88
Testing effectiveness (Phase 2)Study completedNCT00796757
What this trial is testing

Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC).

Who this might be right for
Renal Cell Cancer
Hoffmann-La Roche 146
Large-scale testing (Phase 3)Looking for participantsNCT03592472
What this trial is testing

Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

Who this might be right for
Renal Cell Carcinoma
Xynomic Pharmaceuticals, Inc. 413
Next Page